Table 1.
Baseline Characteristics
| Characteristic | Eradication success (n=63) | Eradication failure (n=25) | Overall (n=88) | p-value |
|---|---|---|---|---|
| Sex | 0.321 | |||
| Male | 40 (63.5) | 13 (52.0) | 53 (60.2) | |
| Female | 23 (36.5) | 12 (48.0) | 35 (39.8) | |
| Age, yr | 58.0 (50.0–65.0) | 56.0 (48.5–64.0) | 57.0 (50.3–64.8) | 0.930 |
| 20–29 | 2 (3.2) | 1 (4.0) | 3 (3.4) | |
| 30–39 | 3 (4.8) | 3 (12.0) | 6 (6.8) | |
| 40–49 | 9 (14.3) | 2 (8.0) | 11 (12.5) | |
| 50–59 | 22 (34.9) | 8 (32.0) | 30 (34.1) | |
| 60–69 | 18 (28.6) | 7 (28.0) | 25 (28.4) | |
| 70–79 | 9 (14.3) | 2 (8.0) | 11 (12.5) | |
| 80–89 | 0 | 2 (8.0) | 2 (2.3) | |
| Geographic area | - | |||
| Seoul | 5 (7.9) | 2 (8.0) | 7 (8.0) | |
| Incheon/Gyeonggi | 42 (66.7) | 18 (72.0) | 60 (68.2) | |
| Chungcheong | 10 (15.9) | 2 (8.0) | 12 (13.6) | |
| Gyeongsang | 4 (6.3) | 0 | 4 (4.5) | |
| Jeju | 2 (3.2) | 3 (12.0) | 5 (5.7) | |
| Type of ulcer | - | |||
| Gastric ulcer | 41 (65.1) | 15 (60.0) | 56 (63.6) | |
| Duodenal ulcer | 19 (30.2) | 8 (32.0) | 27 (30.7) | |
| Gastroduodenal ulcer | 3 (4.8) | 2 (8.0) | 5 (5.7) | |
| Duration, day | 0.353 | |||
| 7 | 25 (39.7) | 6 (24.0) | 31 (35.2) | |
| 10 | 16 (25.4) | 9 (36.0) | 25 (28.4) | |
| 14 | 22 (34.9) | 10 (40.0) | 32 (36.4) | |
| Time | 0.496 | |||
| Before 2010 | 18 (28.6) | 9 (36.0) | 27 (30.7) | |
| After 2010 | 45 (71.4) | 16 (64.0) | 61 (69.3) | |
| Regimen | - | |||
| PAL | 62 (98.4) | 25 (100.0) | 87 (98.9) | |
| PACL | 1 (1.6) | 0 | 1 (1.1) |
Data are presented as number (%) or median (interquartile range).
PAL, proton pump inhibitor-amoxicillin-levofloxacin; PACL, proton pump inhibitor-amoxicillin-clarithromycin-levofloxacin.